The tyrosine kinase inhibitor AG556 reduces serum tumor necrosis factor levels and tissue injury and improves survival in both small and large animal models of Gram-negative infection and sepsis. No data are presently available regarding the effects of AG556 during Gram-positive infection. We are therefore investigating this agent in rats challenged with Staphylococcus aureus. For these studies, we are using a multifactorial study design in which animals are challenged with low or high doses of S. aureus injected either intravenously or intrabronchially. This study design will allow us to determine how the site and severity of infection with S. aureus might alter the effects of AG556 on Gram-positive bacterial infection. This study has been started.
| Qi, Hai-Yan; Daniels, Mathew P; Liu, Yueqin et al. (2011) A cytosolic phospholipase A2-initiated lipid mediator pathway induces autophagy in macrophages. J Immunol 187:5286-92 |
| Qi, Hai-Yan; Shelhamer, James H (2005) Toll-like receptor 4 signaling regulates cytosolic phospholipase A2 activation and lipid generation in lipopolysaccharide-stimulated macrophages. J Biol Chem 280:38969-75 |
| Huang, Xiuli; Pawliczak, Rafal; Yao, Xiang-Lan et al. (2003) Characterization of the human p11 promoter sequence. Gene 310:133-42 |
| Huang, Xiu-li; Pawliczak, Rafal; Yao, Xiang-lan et al. (2003) Interferon-gamma induces p11 gene and protein expression in human epithelial cells through interferon-gamma-activated sequences in the p11 promoter. J Biol Chem 278:9298-308 |
